Brokerages Expect Amdocs Limited (DOX) to Post $1.03 Earnings Per Share

Wall Street brokerages forecast that Amdocs Limited (NASDAQ:DOX) will report $1.03 earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Four analysts have made estimates for Amdocs’ earnings. The lowest EPS estimate is $1.03 and the highest is $1.04. Amdocs reported earnings per share of $0.95 in the same quarter last year, which suggests a positive year over year growth rate of 8.4%. The firm is scheduled to issue its next quarterly earnings results on Thursday, May 9th.

According to Zacks, analysts expect that Amdocs will report full-year earnings of $4.20 per share for the current fiscal year, with EPS estimates ranging from $4.16 to $4.23. For the next financial year, analysts expect that the firm will report earnings of $4.47 per share, with EPS estimates ranging from $4.41 to $4.56. Zacks’ earnings per share calculations are a mean average based on a survey of sell-side research firms that that provide coverage for Amdocs.

Get Amdocs alerts:

Amdocs (NASDAQ:DOX) last released its earnings results on Tuesday, February 5th. The technology company reported $0.98 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.99 by ($0.01). The company had revenue of $1.01 billion during the quarter, compared to analysts’ expectations of $1.01 billion. Amdocs had a net margin of 8.46% and a return on equity of 14.75%. The company’s revenue for the quarter was up 3.5% on a year-over-year basis. During the same quarter last year, the business posted $1.06 earnings per share.

DOX has been the topic of a number of analyst reports. TheStreet cut Amdocs from a “b” rating to a “c+” rating in a research note on Friday, November 9th. Zacks Investment Research cut Amdocs from a “hold” rating to a “sell” rating in a research note on Monday, November 19th. BidaskClub cut Amdocs from a “buy” rating to a “hold” rating in a research note on Wednesday, November 28th. JPMorgan Chase & Co. set a $70.00 price target on Amdocs and gave the company a “hold” rating in a research note on Tuesday, December 11th. Finally, ValuEngine cut Amdocs from a “hold” rating to a “sell” rating in a research note on Friday, February 15th. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating to the stock. The stock has an average rating of “Hold” and an average price target of $71.03.

Institutional investors have recently bought and sold shares of the business. Morgan Dempsey Capital Management LLC acquired a new stake in shares of Amdocs during the fourth quarter worth about $25,000. Riverview Trust Co acquired a new stake in shares of Amdocs during the fourth quarter worth about $27,000. Cutler Group LP acquired a new stake in shares of Amdocs during the fourth quarter worth about $55,000. Oppenheimer Asset Management Inc. acquired a new stake in shares of Amdocs during the fourth quarter worth about $58,000. Finally, Honkamp Krueger Financial Services Inc. acquired a new stake in shares of Amdocs during the third quarter worth about $124,000. Institutional investors own 91.10% of the company’s stock.

Amdocs stock traded up $0.09 during midday trading on Thursday, reaching $56.40. The company’s stock had a trading volume of 1,795,298 shares, compared to its average volume of 1,477,422. Amdocs has a fifty-two week low of $52.60 and a fifty-two week high of $71.72. The stock has a market cap of $7.83 billion, a PE ratio of 15.08, a P/E/G ratio of 1.68 and a beta of 0.53.

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 19th. Shareholders of record on Friday, March 29th will be paid a $0.285 dividend. The ex-dividend date is Thursday, March 28th. This is a boost from Amdocs’s previous quarterly dividend of $0.25. This represents a $1.14 dividend on an annualized basis and a yield of 2.02%. Amdocs’s dividend payout ratio (DPR) is currently 26.74%.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services to the communications, pay TV, entertainment, and media industry service providers worldwide. The company offers amdocsONE a line of services designed for various stages of a service provider's lifecycle, including planning, delivery, implementation, and ongoing support, as well as consumer experience and monetization, media and digital, enterprise and connected society, service-driven network, and services and agile operation solutions.

Featured Article: Systematic Risk

Get a free copy of the Zacks research report on Amdocs (DOX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Leave a Reply

Your email address will not be published. Required fields are marked *